Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Protein and Exercise to Reverse Frailty in OlderR Men and Women Undergoing TAVR: The PERFORM-TAVR Trial

NCT03522454 is registered in ClinicalTrials.gov with Jewish General Hospital as lead sponsor.

NCT NCT03522454
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03522454 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Protein and Exercise to Reverse Frailty in OlderR Men and Women Undergoing TAVR: The PERFORM-TAVR Trial
Lead sponsor
Jewish General Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
March 15, 2019
Completion date
December 1, 2022
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dietary supplements, exercise, frail elderly, postoperative care, rehabilitation, transcatheter aortic valve replacement